Progress Update on STING Agonists as Vaccine Adjuvants

Low antigen immunogenicity poses a significant challenge in vaccine development, often leading to inadequate immune responses and reduced vaccine efficacy. Therefore, the discovery of potent immune-enhancing adjuvants is crucial. STING (stimulator of interferon genes) agonists are a promising class...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Yanru Shen, Weijin Huang, Jianhui Nie, Li Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Subjects:	STING STING agonists vaccine adjuvants infectious diseases cancer
Online Access:	https://www.mdpi.com/2076-393X/13/4/371